Annual D&A
$1.76 M
+$86.00 K+5.14%
31 December 2023
Summary:
Rhythm Pharmaceuticals annual depreciation & amortization is currently $1.76 million, with the most recent change of +$86.00 thousand (+5.14%) on 31 December 2023. During the last 3 years, it has risen by +$1.07 million (+154.78%). RYTM annual D&A is now at all-time high.RYTM Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$385.00 K
-$5000.00-1.28%
30 September 2024
Summary:
Rhythm Pharmaceuticals quarterly depreciation & amortization is currently $385.00 thousand, with the most recent change of -$5000.00 (-1.28%) on 30 September 2024. Over the past year, it has dropped by -$57.00 thousand (-12.90%). RYTM quarterly D&A is now -15.75% below its all-time high of $457.00 thousand, reached on 31 March 2023.RYTM Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$1.60 M
-$57.00 K-3.45%
30 September 2024
Summary:
Rhythm Pharmaceuticals TTM depreciation & amortization is currently $1.60 million, with the most recent change of -$57.00 thousand (-3.45%) on 30 September 2024. Over the past year, it has dropped by -$186.00 thousand (-10.43%). RYTM TTM D&A is now -10.43% below its all-time high of $1.78 million, reached on 30 June 2023.RYTM TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RYTM Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.1% | -12.9% | -10.4% |
| 3 y3 years | +154.8% | +22.2% | +58.0% |
| 5 y5 years | +297.7% | +101.6% | +86.3% |
RYTM Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +154.8% | -15.8% | +22.2% | -10.4% | +58.0% |
| 5 y | 5 years | at high | +297.7% | -15.8% | +130.5% | -10.4% | +131.4% |
| alltime | all time | at high | -15.8% | +613.0% | -10.4% | +2857.4% |
Rhythm Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $385.00 K(-1.3%) | $1.60 M(-3.4%) |
| June 2024 | - | $390.00 K(-3.7%) | $1.65 M(-3.0%) |
| Mar 2024 | - | $405.00 K(-2.9%) | $1.71 M(-3.0%) |
| Dec 2023 | $1.76 M(+5.1%) | $417.00 K(-5.7%) | $1.76 M(-1.4%) |
| Sept 2023 | - | $442.00 K(0.0%) | $1.78 M(0.0%) |
| June 2023 | - | $442.00 K(-3.3%) | $1.78 M(+0.2%) |
| Mar 2023 | - | $457.00 K(+3.4%) | $1.78 M(+6.4%) |
| Dec 2022 | $1.67 M(+44.4%) | $442.00 K(0.0%) | $1.67 M(+7.5%) |
| Sept 2022 | - | $442.00 K(+0.9%) | $1.55 M(+8.9%) |
| June 2022 | - | $438.00 K(+25.1%) | $1.43 M(+9.3%) |
| Mar 2022 | - | $350.00 K(+7.7%) | $1.31 M(+12.9%) |
| Dec 2021 | $1.16 M(+67.8%) | $325.00 K(+3.2%) | $1.16 M(+14.5%) |
| Sept 2021 | - | $315.00 K(-0.6%) | $1.01 M(+16.5%) |
| June 2021 | - | $317.00 K(+57.7%) | $868.00 K(+19.9%) |
| Mar 2021 | - | $201.00 K(+12.9%) | $724.00 K(+4.9%) |
| Dec 2020 | $690.00 K | $178.00 K(+3.5%) | $690.00 K(-1.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | $172.00 K(-0.6%) | $703.00 K(-2.6%) |
| June 2020 | - | $173.00 K(+3.6%) | $722.00 K(-4.5%) |
| Mar 2020 | - | $167.00 K(-12.6%) | $756.00 K(-9.4%) |
| Dec 2019 | $834.00 K(+88.7%) | $191.00 K(0.0%) | $834.00 K(-2.7%) |
| Sept 2019 | - | $191.00 K(-7.7%) | $857.00 K(+11.0%) |
| June 2019 | - | $207.00 K(-15.5%) | $772.00 K(+23.3%) |
| Mar 2019 | - | $245.00 K(+14.5%) | $626.00 K(+41.6%) |
| Dec 2018 | $442.00 K(+98.2%) | $214.00 K(+101.9%) | $442.00 K(+53.5%) |
| Sept 2018 | - | $106.00 K(+73.8%) | $288.00 K(+21.5%) |
| June 2018 | - | $61.00 K(0.0%) | $237.00 K(+3.0%) |
| Mar 2018 | - | $61.00 K(+1.7%) | $230.00 K(+3.1%) |
| Dec 2017 | $223.00 K(+54.9%) | $60.00 K(+9.1%) | $223.00 K(+36.8%) |
| Sept 2017 | - | $55.00 K(+1.9%) | $163.00 K(+50.9%) |
| June 2017 | - | $54.00 K(0.0%) | $108.00 K(+100.0%) |
| Mar 2017 | - | $54.00 K | $54.00 K |
| Dec 2016 | $144.00 K(>+9900.0%) | - | - |
| Dec 2015 | $0.00 | - | - |
FAQ
- What is Rhythm Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals annual D&A year-on-year change?
- What is Rhythm Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals quarterly D&A year-on-year change?
- What is Rhythm Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals TTM D&A year-on-year change?
What is Rhythm Pharmaceuticals annual depreciation & amortization?
The current annual D&A of RYTM is $1.76 M
What is the all time high annual D&A for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high annual depreciation & amortization is $1.76 M
What is Rhythm Pharmaceuticals annual D&A year-on-year change?
Over the past year, RYTM annual depreciation & amortization has changed by +$86.00 K (+5.14%)
What is Rhythm Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of RYTM is $385.00 K
What is the all time high quarterly D&A for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high quarterly depreciation & amortization is $457.00 K
What is Rhythm Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, RYTM quarterly depreciation & amortization has changed by -$57.00 K (-12.90%)
What is Rhythm Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of RYTM is $1.60 M
What is the all time high TTM D&A for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high TTM depreciation & amortization is $1.78 M
What is Rhythm Pharmaceuticals TTM D&A year-on-year change?
Over the past year, RYTM TTM depreciation & amortization has changed by -$186.00 K (-10.43%)